Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
about
Neonatal abstinence syndrome: treatment and pediatric outcomesPharmacologic management of the opioid neonatal abstinence syndromeNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United StatesMid-Gestational Enlargement of Fetal Thalami in Women Exposed to Methadone during Pregnancy.Feeding modalities and the onset of the neonatal abstinence syndrome.Beneficial effects of co-treatment with dextromethorphan on prenatally methadone-exposed offspringShould pregnant women with substance use disorders be managed differently?The use of central nervous system active drugs during pregnancy.Methadone: a review of drug-drug and pathophysiological interactions.Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.The relationship between gestational age and the severity of neonatal abstinence syndrome.Modeling prenatal opioid exposure in animals: Current findings and future directions.The relationship between maternal opiate use, amphetamine use and smoking on fetal growth.The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.The toxic effect of opioid analgesics on human sperm motility in vitro.Safety of Reiki Therapy for Newborns at Risk for Neonatal Abstinence Syndrome.The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome.
P2860
Q24611058-161F65C3-D760-4340-913C-866153088932Q26863355-3348E7BC-22DB-4185-A6EC-E1B548D4F5BDQ30249670-0C5BC29B-F7F5-4D58-8715-04ECF852A32DQ34182409-C2680EEF-42C5-4DB7-BD62-CB03371D690CQ34867955-3909B12A-B199-45BC-9C7D-E74600EB9CDEQ35124322-EF6DD473-454A-4925-A895-474E67805BBAQ35224152-13538DA7-9AAF-4A76-84E2-811174D0FCABQ36464851-273B55AA-214D-4FA3-BCAB-A5B30CEAADD7Q37280003-38FBCFB6-6F5F-4691-976A-3E8BE11193F2Q37950478-8C40CBD1-16DA-4082-BB56-DCF07629F634Q38888611-C81985F8-9D4B-47BB-855F-8E9CD7F9B9A8Q40423803-56F75B3D-FA24-486C-8446-FFD545F3806BQ43075917-2436B7A3-ABA0-43ED-BABA-6275AC27491BQ44259445-2567F8F6-A091-406F-AA3E-39BEB7267A81Q44330446-32C029C4-D627-4325-8D05-1F9C6711C7F2Q44335744-DC6781CA-3C17-45BA-BB7D-3001A41388FBQ47743776-0F01BA2B-BF27-4BEF-8C42-8EB1E4E0072AQ48160111-7CBCDCAB-B193-4D32-B105-D32921C97688Q52312251-A190A524-759C-493F-94CD-98D99FAA23AF
P2860
Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Perinatal risk factors for the ...... methadone maintenance therapy.
@en
Perinatal risk factors for the ...... methadone maintenance therapy.
@nl
type
label
Perinatal risk factors for the ...... methadone maintenance therapy.
@en
Perinatal risk factors for the ...... methadone maintenance therapy.
@nl
prefLabel
Perinatal risk factors for the ...... methadone maintenance therapy.
@en
Perinatal risk factors for the ...... methadone maintenance therapy.
@nl
P2093
P1476
Perinatal risk factors for the ...... methadone maintenance therapy.
@en
P2093
Anthony J W Liu
Colleen-Maree Cook
Henry Murray
Michael P Jones
Ralph Nanan
P304
P356
10.1111/J.1479-828X.2010.01168.X
P577
2010-06-01T00:00:00Z